Caricamento...
A Public Health Approach to the Prevention of Inhibitors in Hemophilia
The development of an antibody in people with hemophilia to products used in the treatment and prevention of bleeding, also referred to as an inhibitor, is the most serious complication of hemophilia care today. CDC, together with healthcare providers, consumer organizations, hemophilia organization...
Salvato in:
| Pubblicato in: | Am J Prev Med |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4469363/ https://ncbi.nlm.nih.gov/pubmed/25245801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amepre.2014.07.007 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|